Humacyte
Humacyte is a North Carolina-based biotechnology company that develops and commercializes novel human acellular matrix products for the treatment of vascular trauma.
Business Model:
Revenue: $1.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Humacyte Information
Geographic Data
Address: 2525 E NC Highway 54
City: Durham
State: NC
Zip: 27713
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$175M
Raised Total:$688M
Social
Metrics
3,576,510Website Global Rank
3,816Website Monthly Traffic
Twitter Followers
Description
Humacyte is a North Carolina-based biotechnology company that develops and commercializes novel human acellular matrix products for the treatment of vascular trauma.
Contact Phone:
+19193139633
Contact Email:
Humacyte went public on 8/27/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/27/2021
IPO Valuation:
$1B
Ticker Symbol:
HUMA
Amount Raised:
$245M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
